Metraipolis › archive › dc_7f81b0eed545

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET® — Europe PMC PMID:41455853

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41455853
DOI
10.1007/s43441-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-07T09:08:28.302Z
SHA-256 of the archived text
1b87c296e66761a19d53864148184dc74694ff986bdbf159e3f7b932f0157c04
Stable URL of this page
https://metraipolis.com/documento/dc_7f81b0eed545

How to cite

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET® — Europe PMC PMID:41455853 — Europe PMC (en), https://europepmc.org/article/MED/41455853 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f81b0eed545 (Metraipolis archive dc_7f81b0eed545, sha256 1b87c296e66761a19d53864148184dc74694ff986bdbf159e3f7b932f0157c04)
BibTeX
@misc{dc7f81b0eed545,
  title = {Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET® — Europe PMC PMID:41455853},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41455853},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f81b0eed545; sha256 1b87c296e66761a19d53864148184dc74694ff986bdbf159e3f7b932f0157c04},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41455853. Agents can read the archived copy with the MCP tool read_document.